Is Sucralose the Healthiest Sugar Substitute?

What the latest research says

Translate to Spanish or other 102 languages!

A study investigates whether sucralose is a safer alternative to gut health compared to sugar. Image for illustration purposes
A study investigates whether sucralose is a safer alternative to gut health compared to sugar. Image for illustration purposes

Medical News Today

- Advertisement -
  • The continual rise in obesity worldwide has reemphasized the need for healthier sugar substitutes. 
  • The past few years have seen various new sugar substitutes become available. 
  • Previous research shows some artificial sweeteners can potentially cause health issues. 
  • Researchers from the University of Vienna found that consuming the artificial sweetener sucralose did not cause an increase in bacterial endotoxin levels in the body, compared to consuming sugar. 

A new study in Austria examined how artificial sweetener sucralose impacts our gut health and found that it may be a safer alternative to consuming sugar.

Follow he link below to Medical News Tday to read the entire article:

https://www.medicalnewstoday.com/articles/is-sucralose-healthiest-sugar-substitute-latest-research-gut-health

- Advertisement -

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

The Truth About Liver Detoxes

Many health trends seem to come and go, but there are some that always find a way of resurfacing – like detoxing your liver.

STHS Children’s Webinar to Help Parents Protect Young Athletes from Sports-Related Injuries, Aug. 19th

Whether competing in youth sports, high school athletics or recreational leagues, young athletes continually push themselves to perform at their best. 

CDC Issues Warning Over Multistate Salmonella Outbreak Linked to Jalapeños

The Centers for Disease Control and Prevention (CDC) has issued a food safety alert following a multistate outbreak of Salmonella infections linked to contaminated jalapeño peppers

New Blood Test Spots Early Signs of Immunotherapy Effectiveness

Researchers at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy determined that liquid biopsy—a blood test that detects circulating tumor DNA (ctDNA)—can predict, within a few weeks, whether patients with advanced non-small cell lung cancer are benefiting from immunotherapy.
- Advertisement -